中东和非洲心脏移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心脏移植和异位心脏移植)、类型(供体活体心脏和人工心脏)和最终用户(医院、心脏中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 60    |    Report Code: BMIRE00030080    |    Category: Life Sciences

Middle East & Africa Heart Transplant Market
中东和非洲心脏移植市场预计将从 2022 年的 2.1352 亿美元增长到 2030 年的 4.3274 亿美元。预计从 2022 年到 2030 年,该市场的复合年增长率将达到 9.2%。

目标疾病发病率的增加促进了中东和非洲心脏移植市场的发展

世界卫生组织 (WHO) 指出,心血管疾病 (CVD) 是全球主要死亡原因之一。导致 CVD 患病率上升的一些主要因素是种族、家族史和年龄。其他值得注意的因素包括烟草消费增加、高胆固醇、高血压;以及肥胖、血脂异常和糖尿病等疾病。根据世界卫生组织的数据,到 2030 年,全球因心血管疾病死亡的人数将从 2016 年的约 1700 万人增加到 2360 万人。此外,到 2030 年,全球心血管疾病的费用负担将从 2010 年的 8630 亿美元增至 10440 亿美元。自 2017 年开业以来,阿拉伯联合酋长国克利夫兰诊所阿布扎比多器官移植中心已完成 386 例移植手术。此外,截至 2023 年,自 1989 年该计划启动以来,沙特阿拉伯 KFSHRC 共进行了 431 多例心脏移植手术。因此,心血管疾病和心力衰竭发病率的上升推动了心脏移植市场的增长。

中东和非洲心脏移植市场概览

中东和非洲心脏移植市场分为阿联酋、沙特阿拉伯、南非和中东及非洲其他地区。该地区老年人口心力衰竭患病率的上升和医疗设施的改善,推动了中东和非洲心脏移植市场的增长。据估计,沙特阿拉伯的心脏移植市场将出现相当大的增长。该国有大量肥胖和老年人口,易患心血管疾病。据世卫组织称,2020 年沙特阿拉伯冠心病死亡人数达到 39,037 人,占总死亡人数的 29.13%。《自然科学与医学科学杂志》发表的一份报告指出,2021 年该国心力衰竭估计人数为 455,222 人,每年新增 37,935 例。冠心病的特点是动脉中脂肪物质的堆积导致心脏阻塞或心脏血流中断;治疗这种疾病需要心脏移植干预。食用橄榄油也会带来心血管相关死亡和全因死亡的风险。

公共组织和政府已经启动了加强该国医疗服务的计划。过去几年,由于投资不断增加,私营部门在沙特阿拉伯的医疗保健系统中发挥着重要作用。沙特阿拉伯政府启动了“沙特愿景 2030”计划,以减少对石油的依赖并实现经济多元化。这导致了医疗服务的重大发展和先进技术的高采用率。2023 年 1 月,沙特医生对一名 8 个月大的女孩进行了心脏移植手术,声称她是中东接受该手术的最年轻的患者。因此,该国心血管疾病和心力衰竭患病率的上升、医疗服务的发展以及政府和私人组织不断增加的投资预计将在未来推动沙特阿拉伯心脏移植市场的增长。

中东和非洲心脏移植市场收入和预测到 2030 年(百万美元)

中东和非洲心脏移植市场细分

中东和非洲心脏移植市场细分为手术类型、类型、最终用户和国家。

根据手术类型,中东和非洲心脏移植市场分为原位心脏移植和异位心脏移植。2022 年,原位心脏移植部分在中东和非洲心脏移植市场中占有较大份额。

就类型而言,中东和非洲心脏移植市场分为供体活体心脏和人工心脏。2022 年,供体活体心脏部分在中东和非洲心脏移植市场中占有较大份额。此外,人工心脏部分分为心室辅助装置和全人工心脏。

根据最终用户,中东和非洲心脏移植市场细分为医院、心脏中心和其他。2022 年,医院部门在中东和非洲心脏移植市场中占有最大份额。

根据国家/地区,中东和非洲心脏移植市场细分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。 2022 年,沙特阿拉伯在中东和非洲心脏移植市场占据主导地位。

Terumo Corp、雅培实验室、SynCardia Systems LLC 和 LivaNova Plc 是中东和非洲心脏移植市场的一些领先公司。

Middle East & Africa Heart Transplant Strategic Insights

Strategic insights for Middle East & Africa Heart Transplant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-heart-transplant-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 213.52 Million
Market Size by 2030 US$ 432.74 Million
Global CAGR (2022 - 2030) 9.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 手术类型
  • 原位心脏移植和异位心脏移植
By 类型
  • 供体活体心脏和人工心脏
By 最终用户
  • 医院
  • 心脏中心
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • LivaNova Plc
  • Get more information on this report

    Middle East & Africa Heart Transplant Regional Insights

    The regional scope of Middle East & Africa Heart Transplant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-heart-transplant-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Heart Transplant Market

    1. Terumo Corp

    2. Abbott Laboratories

    3. SynCardia Systems LLC

    4. LivaNova Plc

     

    Frequently Asked Questions
    How big is the Middle East & Africa Heart Transplant Market?

    The Middle East & Africa Heart Transplant Market is valued at US$ 213.52 Million in 2022, it is projected to reach US$ 432.74 Million by 2030.

    What is the CAGR for Middle East & Africa Heart Transplant Market by (2022 - 2030)?

    As per our report Middle East & Africa Heart Transplant Market, the market size is valued at US$ 213.52 Million in 2022, projecting it to reach US$ 432.74 Million by 2030. This translates to a CAGR of approximately 9.2% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Heart Transplant Market report typically cover these key segments-

  • 手术类型 (原位心脏移植和异位心脏移植)
  • 类型 (供体活体心脏和人工心脏)
  • 最终用户 (医院, 心脏中心)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Heart Transplant Market?

    The Middle East & Africa Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • LivaNova Plc
  • Who should buy this report?

    The Middle East & Africa Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.